Cost-effective strategies exist at the population and individual levels for reducing cardiovascular disease in developing countries, guided by adequate assessment of underlying risk.
Cardiovascular disease (CVD) has become the number-one cause of death in the developing world. This epidemic has the potential to place a large social and economic burden on developing countries, where CVD tends to strike those in their prime working years. Since resources for managing CVD are limited, it is important that interventions be guided by cost-effectiveness results for low- and middle-income countries. Despite the burden, cost-effective strategies exist at the population and individual levels for reducing CVD. Integral to all personal intervention strategies is an adequate assessment of the underlying risk of disease.
Thomas A. Gaziano (Mon,) conducted a review in Cardiovascular disease. Cost-effective strategies for reducing CVD was evaluated. Cost-effective strategies exist at the population and individual levels for reducing cardiovascular disease in developing countries, guided by adequate assessment of underlying risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: